돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 988076생성일: 2026년 10월 25일

(+)-Lariciresinol → (+)-Pinoresinol (+)-Lariciresinol

https://huagongshe.com/reaction/988076

반응식

참여 물질

역할이름HCID투입량
반응물(+)-LariciresinolHCID 332427—
반응물EpipinoresinolHCID 637584—
용매MethanolHCID 887—
생성물(+)-Pinoresinol (+)-LariciresinolHCID 131722472—

반응 조건

온도30 °C

반응 단계

Enzyme Assays. Pinoresinol and lariciresinol reductase activities were assayed by monitoring the formation of [3H]lariciresinol and [3H]secoisolariciresinol as set forth in Example 8, with the following modifications. Briefly, each assay for pinoresinol reductase activity consisted of (±)-pinoresinols (5 mM in MeOH, 20 μl) and the enzyme preparation (i.e., total protein extract from E. coli, 210 μl). The enzymatic reaction was initiated by addition of [4R-3H]NADPH (10 mM, 6.79 kBq/mmol in distilled H2O, 20 μl). After 3 hour incubation at 30° C. with shaking, the assay mixture was extracted with EtOAc (500 μl) containing (±)-lariciresinols (20 μg) and (±)-secoisolariciresinols (20 μg) as radiochemical carriers. After centrifugation (13,800×g, 5 min), the EtOAc solubles were removed and the extraction procedure was repeated. For each assay, the EtOAc solubles were combined with an aliquot (100 μl) removed for determination of its radioactivity using liquid scintillation counting. The remainder of the combined EtOAc solubles was evaporated to dryness in vacuo, reconstituted in MeOH/H2O (30:70, 100 μl) and subjected to reversed phase and chiral column HPLC.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US06635459B1
출처 데이터셋uspto-grants-2003_10
ORD IDord-3355eda6ba77466bab8234bb86e7bfad
출처 메모uspto-grants-2003_10